Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1.
Saved in:
| Title: | Activation of CD44, a receptor for extracellular matrix components, protects chronic lymphocytic leukemia cells from spontaneous and drug induced apoptosis through MCL-1. |
|---|---|
| Authors: | Herishanu, Yair1 (AUTHOR) wiestnera@mail.nih.gov, Gibellini, Federica1 (AUTHOR) wiestnera@mail.nih.gov, Njuguna, Ndegwa1 (AUTHOR), Hazan-Halevy, Inbal2 (AUTHOR), Farooqui, Mohammed1 (AUTHOR), Bern, Sarah1 (AUTHOR), Keyvanfar, Keyvan1 (AUTHOR), Lee, Elinor1 (AUTHOR), Wilson, Wyndham3 (AUTHOR), Wiestner, Adrian1 (AUTHOR) wiestnera@mail.nih.gov |
| Source: | Leukemia & Lymphoma. Sep2011, Vol. 52 Issue 9, p1758-1769. 12p. 5 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
